Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 46901-46950 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06456281
Multi-omics Model for Pancreatic Cancer Screening Using cfDNA
N/ARecruiting
480 participants
Started: Jun 28, 2024 · Completed: Dec 30, 2025
1 condition2 sponsors1 location
NCT06474780
Evaluation of The Effect of Virtual Reality Glasses
N/ANot yet recruiting
900 participants
Started: Jun 28, 2024 · Completed: Aug 25, 2024
5 conditions1 sponsor0 locations
NCT06411808
Evaluating Sensory-Adapted Dental Care in Children With Sensory Processing Disorders
NAActive, not recruiting
20 participants
Started: Jun 28, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06455098
A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF)
NARecruiting
440 participants
Started: Jun 28, 2024 · Completed: May 30, 2026
1 condition1 sponsor46 locations
NCT06494540
NIS to Examine the Effectiveness of TDC in Patients With Metastatic Non-squamous NSCLC and High-risk Genetic Alterations
N/ARecruiting
600 participants
Started: Jun 28, 2024 · Completed: Jun 30, 2028
1 condition1 sponsor18 locations
NCT06170606
POLARx Post Approval Study (POLARx PAS)
NARecruiting
200 participants
Started: Jun 28, 2024 · Completed: May 31, 2029
1 condition1 sponsor11 locations
NCT06514209
Effect of Different Depths of Neuromuscular Blockade on Respiratory Mechanics in Patients With Moderate-severe Acute Respiratory Distress Syndrome
NARecruiting
20 participants
Started: Jun 28, 2024 · Completed: Jun 30, 2025
2 conditions1 sponsor1 location
NCT06458595
Safety and Tolerability of KH658 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (nAMD)
PHASE1/PHASE2Recruiting
44 participants
Started: Jun 28, 2024 · Completed: Dec 28, 2026
1 condition1 sponsor1 location
NCT02880163
REVIVE: Reducing Exsanguination Via In-Vivo Expandable Foam
NARecruiting
40 participants
Started: Jun 28, 2024 · Completed: Jul 28, 2025
4 conditions1 sponsor1 location
NCT06108089
Novel Hypoxia Imaging for Head and Neck Cancer: Imaging Phenotype for Personalized Treatment
N/ARecruiting
20 participants
Started: Jun 28, 2024 · Completed: Dec 1, 2025
4 conditions2 sponsors1 location
NCT06484192
Pain Control After Lumbar Spine Fusion
PHASE4Enrolling by invitation
428 participants
Started: Jun 28, 2024 · Completed: Jun 30, 2025
3 conditions1 sponsor1 location
NCT06502873
Setting up a Cohort of Patients With Crohn's Disease and a Cohort of Patients Without Chronic Inflammatory Bowel Disease
NARecruiting
120 participants
Started: Jun 28, 2024 · Completed: Feb 28, 2026
1 condition1 sponsor1 location
NCT06697080
Umbilical Cord-derived Mesenchymal Stem Cell Exosomes on Hair Growth in Patients With Androgenetic Alopecia
NAActive, not recruiting
50 participants
Started: Jun 28, 2024 · Completed: Dec 28, 2024
1 condition1 sponsor1 location
NCT06545994
A Prospective Cohort Study on the Serum Kisspeptin Levels Throughout Pregnancy in PCOS
N/ARecruiting
180 participants
Started: Jun 28, 2024 · Completed: Jun 30, 2026
2 conditions1 sponsor1 location
NCT06297291
Global Paradise System US Post Approval Study
N/ARecruiting
1,000 participants
Started: Jun 28, 2024 · Completed: Jul 31, 2031
3 conditions1 sponsor32 locations
NCT06819280
Autologous Tumor-Infiltrating Lymphocyte (GT307) for Treatment of Patients with Advanced Colorectal Cancer
NARecruiting
18 participants
Started: Jun 28, 2024 · Completed: May 27, 2027
1 condition1 sponsor1 location
NCT06521944
RSV Vaccine Pregnancy Registry
N/ARecruiting
2,062 participants
Started: Jun 28, 2024 · Completed: Sep 30, 2030
1 condition1 sponsor1 location
NCT06428058
Evaluating the Effects of Reproductive Health Training on Provider Behavior
NAActive, not recruiting
310 participants
Started: Jun 28, 2024 · Completed: Sep 1, 2026
2 conditions3 sponsors1 location
NCT06500728
Visual Involvement in Giant Cell Arteritis
N/ARecruiting
762 participants
Started: Jun 27, 2024 · Completed: Jun 30, 2030
9 conditions1 sponsor1 location
NCT06150703
Luteal Phase Support With GnRH Agonist After GnRH Agonist Triggering in IVF/ICSI Cycles
PHASE3Recruiting
652 participants
Started: Jun 27, 2024 · Completed: Sep 27, 2027
2 conditions1 sponsor1 location
NCT06913712
BMI in Idiopathic Intracranial Hypertension and Its Relationship With the Response to Treatment
N/ARecruiting
25 participants
Started: Jun 27, 2024 · Completed: Apr 1, 2027
1 condition1 sponsor1 location
NCT06916000
Assessment of PENG Block as a Part of Multimodal Analgesia Following Hip Surgeries.
NAActive, not recruiting
50 participants
Started: Jun 27, 2024 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT06369246
PRORAD-5 PROstate RADiation in 5 Fractions: Phase Ib Five Fraction Radiotherapy for Patients With Advanced Prostate Cancer
PHASE1Recruiting
70 participants
Started: Jun 27, 2024 · Completed: Sep 1, 2027
1 condition1 sponsor1 location
NCT05957523
Effects of Remote Ischemic Preconditioning on Peripheral Blood Biomarkers in Healthy Adults (EMINENT)
NARecruiting
60 participants
Started: Jun 27, 2024 · Completed: Dec 12, 2025
1 condition1 sponsor1 location
NCT06536439
Planning Operative Strategy Using a Digital Renal Artery Clamping Tool
NARecruiting
235 participants
Started: Jun 27, 2024 · Completed: Jan 1, 2027
6 conditions3 sponsors5 locations
NCT05671406
RCT of Sensor-controlled Digital Game for Hypertension Self-care in a Native American Community
NARecruiting
220 participants
Started: Jun 27, 2024 · Completed: Mar 31, 2027
1 condition3 sponsors1 location
NCT06491134
Liposomal Irinotecan With Cisplatin and Concurrent Radiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma
PHASE1Not yet recruiting
12 participants
Started: Jun 27, 2024 · Completed: Feb 28, 2028
1 condition1 sponsor0 locations
NCT06877988
Artificial Intelligence (AI) - Assisted Visual Impairment Screening Model: Community-based Implementation and Evaluation of Performance, Feasibility and Costs.
NARecruiting
400 participants
Started: Jun 27, 2024 · Completed: Mar 31, 2026
1 condition3 sponsors1 location
NCT06277661
The Mom and Infant Outcomes (MOMI) Study
NARecruiting
384 participants
Started: Jun 27, 2024 · Completed: Mar 1, 2028
3 conditions1 sponsor1 location
NCT06349590
Manipulation of the Gut Microbiome by a Standardized Preoperative Diet to Prevent Colorectal Cancer Recurrence and Metastasis Following Surgery
PHASE1/PHASE2Recruiting
80 participants
Started: Jun 27, 2024 · Completed: Oct 31, 2029
1 condition1 sponsor1 location
NCT06415838
Behavioral Activation for the Prevention and Treatment of Depression in Older Adults in a Municipal Context
NARecruiting
160 participants
Started: Jun 27, 2024 · Completed: Aug 31, 2026
2 conditions2 sponsors1 location
NCT06512324
Operation of Brain Stimulation Equipment Under Remote Viewing Effectiveness Registry
N/AEnrolling by invitation
5,000 participants
Started: Jun 27, 2024 · Completed: Dec 31, 2029
6 conditions1 sponsor2 locations
NCT06888726
Efficacy of Hi-tACS for Schizophrenia Negative Symptoms
NARecruiting
60 participants
Started: Jun 27, 2024 · Completed: Nov 30, 2026
2 conditions1 sponsor1 location
NCT05694247
Study to Evaluate the Clinical Safety and Performance of the CorNeat KPro for Treatment of Corneal Blindness
NARecruiting
40 participants
Started: Jun 27, 2024 · Completed: Mar 31, 2026
3 conditions1 sponsor6 locations
NCT06384417
Using an End-of-life Conversation Game to Engage Patients With Cancer in Advance Care Planning: Phase 2
NAActive, not recruiting
32 participants
Started: Jun 27, 2024 · Completed: Dec 31, 2026
9 conditions1 sponsor1 location
NCT05799378
Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease
PHASE3Recruiting
330 participants
Started: Jun 27, 2024 · Completed: Jun 30, 2029
1 condition2 sponsors10 locations
NCT06167512
Metabolic Reprogramming in Renal Tubular Cells in Acute Kidney Injury Following Severe Trauma
N/ARecruiting
80 participants
Started: Jun 27, 2024 · Completed: Oct 27, 2025
1 condition1 sponsor2 locations
NCT06551246
Efficacy of Solifenacin, Mirabegron and Combination Therapy in Children with Daytime Urinary Incontinence (BeDry)
PHASE3Recruiting
236 participants
Started: Jun 27, 2024 · Completed: Dec 1, 2027
1 condition1 sponsor5 locations
NCT06280274
Metformin Use in Patients Undergoing Total Joint Replacement Surgery
PHASE4Recruiting
40 participants
Started: Jun 27, 2024 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT06644261
Transvaginal Versus Fluoroscopy-guided Trans Gluteal Pudendal Nerve Block for Pudendal Neuralgia
PHASE4Recruiting
40 participants
Started: Jun 27, 2024 · Completed: Jul 1, 2029
2 conditions1 sponsor1 location
NCT06408220
Risk Assessment Evaluation for Identifying Participants at High Risk for Stomach Cancer
NARecruiting
240 participants
Started: Jun 27, 2024 · Completed: Oct 9, 2026
1 condition2 sponsors1 location
NCT06410703
CAN1012 Combined With PD-1 in Patients With Solid Tumors
PHASE1/PHASE2Recruiting
71 participants
Started: Jun 27, 2024 · Completed: May 30, 2026
1 condition1 sponsor1 location
NCT05224960
Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-2)
PHASE2Recruiting
140 participants
Started: Jun 27, 2024 · Completed: Jun 20, 2027
1 condition9 sponsors7 locations
NCT06347068
Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells
PHASE1Recruiting
42 participants
Started: Jun 27, 2024 · Completed: May 31, 2028
4 conditions3 sponsors1 location
NCT06464679
An Exploratory Clinical Study of CD19 CAR NK Cell Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases
PHASE1Recruiting
72 participants
Started: Jun 27, 2024 · Completed: Jun 30, 2026
1 condition2 sponsors1 location
NCT06485778
A Study of Radiation Therapy After Surgery in People With Oral Tongue Squamous Cell Carcinoma
PHASE2Recruiting
24 participants
Started: Jun 27, 2024 · Completed: Jun 30, 2026
1 condition1 sponsor7 locations
NCT06466980
Study of Ventilator Associated Event During Intensive Care After Resuscitated Cardiac Arrest.
N/ARecruiting
150 participants
Started: Jun 27, 2024 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT06099379
Modulation of THC Effects by CBD: a Dose-ranging Study
PHASE1/PHASE2Recruiting
100 participants
Started: Jun 27, 2024 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT06452771
A First In Human (FIH) Study to Learn if Different Doses of ALN-ANG3 Are Safe and Well Tolerated in Healthy Adults
PHASE1Active, not recruiting
42 participants
Started: Jun 27, 2024 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT06298357
Virtual Reality Gaming for Exercise and Mindfulness Among Pediatric Cancer Rehabilitation
PHASE1Recruiting
16 participants
Started: Jun 27, 2024 · Completed: Mar 31, 2026
1 condition1 sponsor1 location